Challenges and suggestions for human genetic resource management in international cooperation of medical institutions caused by the Implementation Rules of the Regulations on the Management of Human Genetic Resources: A case study of Peking University Cancer Hospital
10.3760/cma.j.cn113565-20231015-00088
- VernacularTitle:《人类遗传资源管理条例实施细则》对医疗机构国际合作中人类遗传资源管理带来的挑战及应对建议
- Author:
Shuanglei KONG
1
;
Yunfei GENG
;
Luopei WEI
;
Lingling BAI
;
Shuqin JIA
Author Information
1. 北京大学肿瘤医院暨北京市肿瘤防治研究所 100142
- Keywords:
Human genetic resource;
Management;
Regulations;
Detailed rules;
Medical institutions
- From:
Chinese Journal of Medical Science Research Management
2024;37(1):18-21
- CountryChina
- Language:Chinese
-
Abstract:
Objective:According to the international cooperation project of Peking University Cancer Hospital on human genetic resource management practices, combined with the development direction of human genetic resource management laws and regulations, and propose reference suggestions for medical institutions to strengthen human genetic resource management.Methods:Sort out the projects that Peking University Cancer Hospital obtained international cooperation approval on the government platform of the Ministry of Science and Technology from July 2019 to June 2023, analyze the current situation of human genetic resource management in the hospital, summarize the challenges brought by the implementation of new regulations on human genetic resource management in medical institutions, and propose corresponding suggestions.Results:A total of 1276 international cooperation projects on human genetic resources have been approved, including 345 initial declarations and 931 change declarations. Involving 453 studies, including 286 clinical trials of drugs or devices on the market, accounting for 63.13%, and 100 clinical trials of Phase I drugs, accounting for 34.97% of the market studies. On average, there are 3.14 changes per project for listed research, and 1.56 changes per project for non listed research.Conclusions:Regulations on the Management of Human Genetic Resources ( short for Rules) limit the management scope of international cooperation projects involving human genetic resources and delegate management authority to medical institutions. Adjusting the scope of application for international cooperative clinical trial filing may result in some administrative approval projects being transferred to filing. The approval process for international cooperative scientific research projects on human genetic resources has been adjusted. Suggest medical institutions to strengthen the management of samples and intellectual property outside the scope of application of Rules.Strengthen the entire process management of international cooperation in scientific research. Pay attention to and timely communicate the dynamics of human genetic resource management.
